Navigation Links
Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia
Date:2/14/2012

CHATTANOOGA, Tenn., Feb. 14, 2012 /PRNewswire/ -- Glenveigh Medical  announced today that the U.S. Food and Drug Administration (FDA) has granted its request for orphan drug designation for a potential new therapy to treat severe preeclampsia and eclampsia. The compound, digoxin immune fab (ovine), is an existing biologic approved for use in cases of digoxin toxicity. Glenveigh, a nationally renowned life science company, has extensive clinical and in vitro evidence to support continued development of this late-stage opportunity. Preeclampsia occurs in 5-8% of pregnancies in the U.S., and these severe forms are leading causes of maternal and perinatal mortality globally.

"This is a tremendous milestone for our company," stated C. David Adair, M.D., Founder, Chairman, and Chief Scientific Officer of Glenveigh. "As a physician and scientist, I have personally seen the devastation these conditions have caused to both moms and babies.  Our program, which includes two successful Phase II studies, offers hope to patients that there will be a treatment for severe preeclampsia in the near future."

Preeclampsia is a condition in pregnant women that is characterized by high blood pressure and excess protein in the urine in the second and third trimesters of pregnancy. Severe preeclampsia and eclampsia represent the most advanced stages of the disease in which pregnant women can suffer from seizures and organ failure.

"In addition to our patents, orphan designation gives Glenveigh at least 7 years of marketing exclusivity," noted Rick Proctor, President and CEO. "We are delighted that the FDA granted orphan drug designation which gives innovators added incentives to pursue treatments for smaller patient populations."

Eleni Tsigas, Executive Director of the Preeclampsia Foundation, added, "Severe preeclampsia can be life-threatening to mother and baby.  Effective interventions for this serious disorder of pregnancy are lacking. We are thrilled that this designation can better enable further research and development that may lead to a potential therapy."

ABOUT GLENVEIGH MEDICAL | www.glenveigh.com  

Glenveigh Medical is a life science and technology based company focused on advancing the practice of obstetrics. Founded in 2004 by a maternal-fetal medicine specialist, Glenveigh prides itself on bringing innovative solutions to the obstetrics industry, relying upon its scientific and medical advisors to provide guidance on market opportunities that will significantly benefit patients in need. Glenveigh's marketed products include the following medical devices: ebb® (post partum hemorrhage), jetty® (vaginal repairs), and Beacon™ (wireless fetal monitor). Glenveigh is based in Chattanooga, Tennessee.


'/>"/>
SOURCE Glenveigh Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
2. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
3. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
4. Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research
5. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
6. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
7. CORD:USE Cord Blood Bank Featured Internationally on CNN en Espanol
8. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
9. Lilly Recognized as a Top Company for Executive Women
10. The Lanier Law Firms Dana Taschner Recognized Among Southern Californias Top Lawyers
11. nContacts Corporate Website Recognized as Best in Class Medical Site by Interactive Media Council - www.ncontactinc.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/10/2017)... 10, 2017 Hologic, Inc. (Nasdaq: ... the fiscal second quarter ended April 1, 2017 . ... increased 666.7% compared to the prior year period as ... a significant gain, while non-GAAP diluted EPS of $0.50 ... 3.8% in constant currency terms.  Excluding the effects of ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... ... dentist? You should go twice per year for checkups, but if you want to keep ... some dental tips to help out: , 1. Brushing Teeth - Brush your teeth twice ... locker at school for a quick brushing after lunch. Use a small brush head with ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to announce the ... USA Today, which will educate readers on how to take care of all aspects ... focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, shares her ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Amir ... Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS ... , “We are pleased to be the first in Arkansas to introduce the most ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating is proud to ... task chair specifically designed for clinical areas. Genie Copper Mesh is a crossover ... Cupron® to provide customers with a game changing chair that is affordably priced,” ...
(Date:5/26/2017)... ... May 26, 2017 , ... Silver Birch of Hammond, a ... located on more than four acres of land at 5620 Sohl Avenue in Hammond, ... 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of the private apartments ...
Breaking Medicine News(10 mins):